Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 103 Records) |
| Query Trace: Disease and meta-analysis and EGFR[original query] |
|---|
| Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in cancer research & treatment 2022 9 21 15330338221128414. Sun Dantong, Tao Junyan, Yan Weihua, Zhu Jingjuan, Zhou Hai, Sheng Yingying, Xue Chaofan, Li Hong, Hou Hel |
| Serum bilirubin and kidney function: a Mendelian randomization study. Clinical kidney journal 2022 Sep 15 (9): 1755-1762. Park Sehoon, Lee Soojin, Kim Yaerim, Lee Yeonhee, Kang Min Woo, Kim Kwangsoo, Kim Yong Chul, Han Seung Seok, Lee Hajeong, Lee Jung Pyo, Joo Kwon Wook, Lim Chun Soo, Kim Yon Su, Kim Dong |
| Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis. Frontiers in oncology 2022 12 863666. Yi Xiao-Fang, Song Jun, Gao Ruo-Lin, Sun Li, Wu Zhi-Xuan, Zhang Shu-Ling, Huang Le-Tian, Ma Jie-Tao, Han Cheng- |
| Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials. BMC cancer 2022 3 22 (1): 328. Zhao Pengfei, Zhen Hongchao, Zhao Hong, Zhao Lei, Cao Bangw |
| Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis. Targeted oncology 2022 Feb . Van Sanden Suzy, Murton Molly, Bobrowska Anna, Rahhali Nora, Sermon Jan, Rodrigues Bernardo, Goff-Leggett Danielle, Chouaid Christos, Sebastian Martin, Greystoke Alasta |
| Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis. European journal of radiology open 2022 2 9 100400. Ortiz Andrés Felipe Herrera, Camacho Tatiana Cadavid, Vásquez Andrés Francisco, Del Castillo Herazo Valeria, Neira Juan Guillermo Arámbula, Yepes María Mónica, Camacho Eduard Cadav |
| Interpretation of Lung Cancer Plasma EGFR Mutation Tests in the Clinical Setting. American journal of clinical pathology 2022 12 159 (2): 181-191. Cheung Alvin Ho-Kwan, Wong Kit-Yee, Chiang Cho-Han, Liu Xiaoli, Zhang Yihan, Hui Chris Ho-Lam, Chen Bonan, Wang Yifei, Chow Chit, Kang Wei, To Ka-F |
| Effects of Selenium on Chronic Kidney Disease: A Mendelian Randomization Study. Nutrients 2022 11 14 (21): . Fu Shaojie, Zhang Li, Ma Fuzhe, Xue Shuai, Sun Tao, Xu Zhongg |
| Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General Population. American journal of kidney diseases : the official journal of the National Kidney Foundation 2022 10 . Kestenbaum Bryan, Bick Alexander G, Vlasschaert Caitlyn, Rauh Michael J, Lanktree Matthew B, Franceschini Nora, Shoemaker Moore B, Harris Raymond C, Psaty Bruce M, Köttgen Anna, Natarajan Pradeep, Robinson-Cohen Cassian |
| Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies. Acta oncologica (Stockholm, Sweden) 2022 10 61 (11): 1347-1353. Li Li, Huang Qin, Sun Jianhai, Yan Fei, Wei Wujie, Li Zihui, Liu Li, Deng J |
Genome-Wide Association Study for eGFR in a Taiwanese Population.
Clinical journal of the American Society of Nephrology : CJASN 2022 Oct . Chen Ying-Chun, Wong Henry Sung-Ching, Wu Mei-Yi, Chou Wan-Hsuan, Kao Chih-Chin, Chao Ching-Hsuan, Chang Wei-Chiao, Wu Mai-S |
| Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy.
Blood advances 2022 11 . Garrett Melanie E, Soldano Karen L, Erwin Kyle N, Zhang Yingze, Gordeuk Victor R, Gladwin Mark T, Telen Marilyn J, Ashley-Koch Allison |
| Nidogen-1 could play a role in diabetic kidney disease development in type 2 diabetes: a genome-wide association meta-analysis.
Human genomics 2022 10 16 (1): 47. Khattab Ahmed, Torkamani A |
| Genome-Wide Association Study of Chronic Kidney Disease Progression. Journal of the American Society of Nephrology : JASN 2023 6 . C Robinson-Cohen, J L Triozzi, B Rowan, J He, H C Chen, N S Zheng, W Q Wei, O D Wilson, J N Hellwege, P S Tsao, J M Gaziano, A Bick, M E Matheny, C P Chung, L Lipworth, E D Siew, T A Ikizler, R Tao, A M Hu |
| Should We Perform Repeated Re-Biopsy for the Detection of T790M Mutation? Cancer research and treatment 2023 4 . Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop E |
| Epidermal growth factor receptor inhibitors as adjuvant treatment for patients with resected non-small cell lung cancer harboring EGFR mutation: a meta-analysis of randomized controlled clinical trials. World journal of surgical oncology 2023 2 21 (1): 45. Zhao Ning, Wu Zhuo-Peng, Yang Jie, Feng Wei-Neng, Yang Sheng-Li, Luo Ying, Ye Jun, Wang Fei, Zhang Xiao-Wen, Xiao Ye, Wu Ling-Ling, Gu Wei-Qu |
| Influence of Smoking Habits on the Efficacy of EGFR-TKI Therapy in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis. Clinical Medicine Insights. Oncology 2023 12 17 11795549231215968. Zexun Mo, Meifeng Ye, Hua He, Xiaomei Huang, Weihong Guo, Ziwen Zhao, Yujun Li, Shuquan W |
| Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis. Clinical lung cancer 2023 11 . Fumihiro Kashizaki, Hao Chen, Atsushi Miyasaka, Nanami Tsuchiya, Chihiro Yamada, Shunsuke Okazaki, Mai Kaneko, Taiki Kano, Yohei Kameda, Akitomo Kikuchi, Kentaro Yumoto, Hiroyuki Osawa, Harumi Koizumi, Kenichi Takahashi, Takeshi Kane |
| Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy. Journal for immunotherapy of cancer 2023 10 11 (10): . Zichun Li, Xuanye Zhang, Yuhong Wang, Zhixin Yu, Chunlong Yang, Yixin Zhou, Shaodong Ho |
| Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer 2023 1 14 (6): 535-543. Dai Jiali, Liu Xinyin, Li Jun, Qu Tianyu, Cui Yanan, Jin Shidai, Zhang Erbao, Guo Renh |
| Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non?small?cell lung cancer: A meta analysis. Clinics (Sao Paulo, Brazil) 2023 1 78 100152. Yi Min, He Ting, Wang Kaijin, Wei Yongga |
| Immunotherapy plus chemotherapy for patients with EGFR-mutated non-squamous cell lung cancer for disease progression after EGFR tyrosine-kinase inhibitor: A meta-analysis of randomized controlled trials. Oncology 2024 9 1-26. Ahmed A Refae, Rafat I Abu Shakra, Ezzeldin M Ibrah |
| Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment. American journal of clinical oncology 2024 9 . Zaheer Qureshi, Faryal Altaf, Abdur Jamil, Rimsha Siddiq |
| A meta-analysis of liquid biopsy versus tumor histology for detecting EGFR mutations in non-small cell lung cancer. Translational oncology 2024 7 47 102022. Jing Cai, Wanning Wang, Wenlong Zha |
| Clonal hematopoiesis of indeterminate potential contributes to accelerated chronic kidney disease progression. medRxiv : the preprint server for health sciences 2024 7 . Caitlyn Vlasschaert, Yang Pan, Jianchun Chen, Elvis Akwo, Varun Rao, James E Hixson, Michael Chong, Md Mesbah Uddin, Zhi Yu, Mengdi Jiang, Fenfen Peng, Shirong Cao, Yinqiu Wang, Do-Kyun Kim, Adriana M Hung, Jing He, Manjula Kurella Tamura, Debbie L Cohen, Jiang He, Changwei Li, Zeenat Bhat, Panduranga Rao, Dawei Xie, Alexander G Bick, Bryan Kestenbaum, Guillaume Paré, Michael J Rauh, Adeera Levin, Pradeep Natarajan, James P Lash, Ming-Zhi Zhang, Raymond C Harris, Cassianne Robinson-Cohen, Matthew B Lanktree, Tanika N Kelly, |
| Association of 10 Polymorphisms in PLA2R1 and HLA DQA1 Genes with Primary Membranous Nephropathy Risk: A Meta-Analysis and a Meta-Regression. Biomarker insights 2024 6 19 11772719241259602. Tarak Dhaouadi, Awatef Riahi, Taïeb Ben Abdallah, Yousr Gorgi, Imen Sf |
| Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer. Chinese medical journal 2024 12 . Xin Dai, Qian Xu, Lei Sheng, Xue Zhang, Miao Huang, Song Li, Kai Huang, Jiahui Chu, Jian Wang, Jisheng Li, Yanguo Liu, Jianyuan Zhou, Shulun Nie, Lian L |
| Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis. JCO precision oncology 2024 11 8 e2400331. Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes, Isabella Michelon, Caio Castro, Natasha B Leighl, Ludimila Cavalcante, Alfredo Addeo, Jair Bar, Nobuyuki Horita, Alessio Cortellini, Amin H Nassar, Maysa Vilbert, Abdul Rafeh Naqa |
| Efficacy of Adjuvant First-Generation TKIs versus Chemotherapy in Patients with Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis. Cancer investigation 2024 1 1-12. Bin Shen, Dongping Wu, Jianjiang Liu, Yang Ya |
| The causal relationship between COVID-19 and estimated glomerular filtration rate: a bidirectional Mendelian randomization study. BMC nephrology 2024 1 25 (1): 21. Qiuling Li, Mengjiao Lin, Yinghui Deng, Haozhang Hua |
- Page last reviewed:Feb 1, 2024
- Content source: